Robert Snijder

713 total citations
25 papers, 380 citations indexed

About

Robert Snijder is a scholar working on Rheumatology, Urology and Epidemiology. According to data from OpenAlex, Robert Snijder has authored 25 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 9 papers in Urology and 8 papers in Epidemiology. Recurrent topics in Robert Snijder's work include Pelvic floor disorders treatments (9 papers), Urinary Bladder and Prostate Research (9 papers) and Urinary Tract Infections Management (7 papers). Robert Snijder is often cited by papers focused on Pelvic floor disorders treatments (9 papers), Urinary Bladder and Prostate Research (9 papers) and Urinary Tract Infections Management (7 papers). Robert Snijder collaborates with scholars based in Netherlands, United Kingdom and Japan. Robert Snijder's co-authors include Stephen Long, Nathaniel P. Katz, Malcolm Stoker, Christopher R. Chapple, Tomomi Kimura, Joanna Van, David M. Simpson, Jessica Robinson‐Papp, Karel Everaert and Malcolm G Lucas and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Urology.

In The Last Decade

Robert Snijder

21 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Snijder Netherlands	10	158	136	111	103	98	25	380
David O. Prichard United States	13	105 0.7×	14 0.1×	185 1.7×	16 0.2×	30 0.3×	43	628
Patrick Gatmaitan United States	7	122 0.8×	17 0.1×	61 0.5×	2 0.0×	66 0.7×	9	384
Yining Xie China	9	65 0.4×	49 0.4×	6 0.1×	5 0.0×	40 0.4×	15	343
P. Quinn United Kingdom	6	129 0.8×	38 0.3×	196 1.8×	1 0.0×	49 0.5×	12	462
Micha Milovanovic Sweden	11	81 0.5×	2 0.0×	43 0.4×	18 0.2×	26 0.3×	24	328
J. L. Selam France	12	60 0.4×	32 0.2×	6 0.1×	12 0.1×	30 0.3×	31	843
Thomas Mouillot France	13	104 0.7×	11 0.1×	5 0.0×	12 0.1×	275 2.8×	31	574
Rui He China	9	56 0.4×	9 0.1×	5 0.0×	16 0.2×	37 0.4×	24	290
Anna Rita Maurizi Italy	10	61 0.4×	3 0.0×	10 0.1×	25 0.2×	25 0.3×	20	415

Countries citing papers authored by Robert Snijder

Since Specialization

Citations

This map shows the geographic impact of Robert Snijder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Snijder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Snijder more than expected).

Fields of papers citing papers by Robert Snijder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Snijder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Snijder. The network helps show where Robert Snijder may publish in the future.

Co-authorship network of co-authors of Robert Snijder

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Snijder. A scholar is included among the top collaborators of Robert Snijder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Snijder. Robert Snijder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bahl, Amit, Rita Faria, Axel S. Merseburger, et al.. (2025). Attributes and Health Care Resource Utilization of Patients on Enzalutamide or Abiraterone for Metastatic Castration-Resistant Cancer in England. JCO Oncology Practice. 22(2). 274–284. 1 indexed citations

Bahl, Amit, et al.. (2025). Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World Journal of Urology. 43(1). 465–465.

Merseburger, Axel S., et al.. (2023). New or worsening type 2 diabetes mellitus (T2DM) in men treated with enzalutamide (ENZ) or abiraterone acetate (AA) for metastatic castration-resistant prostate cancer (mCRPC): EVADE study. European Urology Open Science. 57. S165–S165.

Rivas, Juan Gómez, Rossella Nicoletti, Asieh Golozar, et al.. (2023). 1796P Real-world analysis of metastatic hormone-sensitive prostate cancer: Are randomized clinical trials more trustworthy? Insights from PIONEER, the European network of excellence for big data in prostate cancer. Annals of Oncology. 34. S971–S971. 1 indexed citations

Snijder, Robert, et al.. (2022). Incidence, prevalence, and treatment patterns in metastatic hormone-sensitive prostate cancer in Spain: ECHOS study. Actas Urológicas Españolas (English Edition). 46(9). 557–564. 2 indexed citations

Abiru, Norio, et al.. (2022). Demographic and clinical characteristics of patients with type 1 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors in Japan: A real-world administrative database analysis. Diabetes Research and Clinical Practice. 190. 109973–109973. 3 indexed citations

Minutolo, Roberto, Giuseppe Grandaliano, Robert Snijder, et al.. (2022). Prevalence, incidence, and treatment of anaemia in patients with non-dialysis-dependent chronic kidney disease: findings from a retrospective real-world study in Italy. Journal of Nephrology. 36(2). 347–357. 5 indexed citations

Kimura, Tomomi, Robert Snijder, & Kazutoshi Nozaki. (2020). Diagnosis Patterns of CKD and Anemia in the Japanese Population. Kidney International Reports. 5(5). 694–705. 12 indexed citations

Snijder, Robert, et al.. (2020). Relationship between mean volume voided and incontinence in children with overactive bladder treated with solifenacin: post hoc analysis of a phase 3 randomised clinical trial. European Journal of Pediatrics. 179(10). 1523–1528. 3 indexed citations

10.

Kimura, Tomomi, et al.. (2019). Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset. Journal of Infection and Chemotherapy. 25(8). 615–620. 18 indexed citations

11.

Franco, Israel, Piet Hoebeke, Leon N. Davies, et al.. (2019). Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies. Journal of Pediatric Urology. 16(2). 180.e1–180.e8. 14 indexed citations

12.

Drake, Marcus J., et al.. (2017). Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies. PLoS ONE. 12(2). e0170726–e0170726. 13 indexed citations

13.

Newgreen, Donald, R. Besuyen, Robert Snijder, et al.. (2017). Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder. The Journal of Urology. 198(4). 928–936. 15 indexed citations

14.

Herschorn, Sender, Christopher R. Chapple, Robert Snijder, Emad Siddiqui, & Linda Cardozo. (2017). Could Reduced Fluid Intake Cause the Placebo Effect Seen in Overactive Bladder Clinical Trials? Analysis of a Large Solifenacin Integrated Database. Urology. 106. 55–59. 8 indexed citations

15.

Snijder, Robert, et al.. (2016). A novel standard to evaluate the impact of therapeutic agents on patient safety – The BURDEN OF THERAPY™©∗. Contemporary Clinical Trials Communications. 4. 186–191. 9 indexed citations

16.

Simpson, David M., Jessica Robinson‐Papp, Joanna Van, et al.. (2016). Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of Pain. 18(1). 42–53. 103 indexed citations

17.

Cardozo, Linda, Sender Herschorn, Robert Snijder, Emad Siddiqui, & Christopher R. Chapple. (2016). Does BMI, gender or age affect efficacy/tolerability of solifenacin in the management of overactive bladder?. International Urogynecology Journal. 28(3). 477–488. 13 indexed citations

18.

Vinik, Aaron I., Serge Perrot, Etta J. Vinik, et al.. (2016). Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study. BMC Neurology. 16(1). 251–251. 69 indexed citations

19.

Chapple, Christopher R., Linda Cardozo, Robert Snijder, Emad Siddiqui, & Sender Herschorn. (2016). Pooled solifenacin overactive bladder trial data: Creation, validation and analysis of an integrated database. Contemporary Clinical Trials Communications. 4. 199–207. 2 indexed citations

20.

Chapple, Christopher R., G. Amarenco, Karel Everaert, et al.. (2013). A proof‐of‐concept study: Mirabegron, a new therapy for overactive bladder. Neurourology and Urodynamics. 32(8). 1116–1122. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact